A third-generation bisphosphonate, Minodronic acid (YM529), augments the interferon α/β-mediated inhibition of renal cell cancer cell growth both in vitro and in vivoYUASA, Takeshi; NOGAWA, Masaki; KIMURA, Shinya et al.Clinical cancer research. 2005, Vol 11, Num 2, pp 853-859, issn 1078-0432, 7 p., 1Article

Zoledronic acid mediates ras-independent growth inhibition of prostate cancer cellsNOGAWA, Masaki; YUASA, Takeshi; KIMURA, Shinya et al.Oncology research. 2005, Vol 15, Num 1, pp 1-9, issn 0965-0407, 9 p.Article

Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell linesKIMURA, Shinya; KURODA, Junya; SEGAWA, Hidekazu et al.International journal of hematology. 2004, Vol 79, Num 1, pp 37-43, issn 0925-5710, 7 p.Article

Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell linesMATSUMOTO, Seiji; KIMURA, Shinya; SEGAWA, Hidekazu et al.Lung cancer. 2005, Vol 47, Num 1, pp 31-39, issn 0169-5002, 9 p.Article

p53-independent anti-tumor effects of the nitrogen-containing bisphosphonate zoledronic acidKURODA, Junya; KIMURA, Shinya; MAEKAWA, Taira et al.Cancer science. 2004, Vol 95, Num 2, pp 186-192, issn 1347-9032, 7 p.Article

Cytotoxic effects of γδ T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapySATO, Kiyoshi; KIMURA, Shinya; MAEKAWA, Taira et al.International journal of cancer. 2005, Vol 116, Num 1, pp 94-99, issn 0020-7136, 6 p.Article

Rapid quantitation of immunoglobulin G antibodies specific for blood group antigens A and B by surface plasmon resonanceKIMURA, Shinya; YURUGI, Kimiko; SEGAWA, Hidekazu et al.Transfusion (Philadelphia, PA). 2005, Vol 45, Num 1, pp 56-62, issn 0041-1132, 7 p.Article

NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemiaKIMURA, Shinya; NAITO, Haruna; NAKAYA, Yohei et al.Blood. 2005, Vol 106, Num 12, pp 3948-3954, issn 0006-4971, 7 p.Article

Inhibition of leukemic cell growth by a novel anti-cancer drug (GUT-70) from Calophyllum brasiliense that acts by induction of apoptosisKIMURA, Shinya; ITO, Chihiro; FURUKAWA, Hiroshi et al.International journal of cancer. 2005, Vol 113, Num 1, pp 158-165, issn 0020-7136, 8 p.Article

Zoledronate synergises with imatinib mesylate to inhibit Ph⁺ primary leukaemic cell growthSEGAWA, Hidekazu; KIMURA, Shinya; OTTMANN, Oliver G et al.British journal of haematology. 2005, Vol 130, Num 4, pp 558-560, issn 0007-1048, 3 p.Article

The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph⁺ leukemia activity of imatinib mesylateKURODA, Junya; KIMURA, Shinya; MAEKAWA, Taira et al.Blood. 2003, Vol 102, Num 6, pp 2229-2235, issn 0006-4971, 7 p.Article